Gene Therapy Could End Lifelong Transfusions For Rare Blood Disorder

A single one-time gene therapy could free patients with α-thalassemia, a rare and debilitating blood disorder, from the burden of lifelong transfusions. For patients, this would mean liberation from weekly or monthly hospital visits, reduced risk of organ damage caused by iron overload, and a vastly improved…